announcement coming, page-46

"Several European companies with whom we have been in dialogue for some time have finally identified what they believe to be opportunities that would benefit GREATLY from the use
of Mix&Go, both in the short and long term. Dr Joe Maeji and I will meet relevant people to assess their needs and the likelihood that we can be of commercial benefit. The audience includes scientific, clinical and commercial staff from RESEARCH, PHARMA and DIAGNOSTIC areas of their respective businesses. We are excited by the prospects and look forward to investigating the variety of applications requested.

The year has begun well for us. We look forward to keeping you abreast of our progress."


Hmmmm.. Sounds like Roche to me - Time will tell

Roche Penzberg